Part I. 3. Requirements for Risk Management Systems. Guidelines on Pharmacovigilance for Medicinal Products for Human Use-. 2008, 36-55
Title IX Enhanced Authorities Regarding Postmarketing Safety of Drugs. Sec. 505-1 Risk Evaluation and Mitigation Strategies. The Food and Drug Administration. Amendments Act of 2007
WYSOWSKI, DK. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002. Arch Intern Med. 2005, 165, 1363-1369